Aker BioMarine

Sustainable Demand Will Redefine Marine Omega-3 Nutrition

AnalystHighTarget

Not Invested

Community Contributor

Published

14 Jul 25

AnalystHighTarget's Fair Value

NOK 75.11

12.2% overvalued

20 Aug

NOK 84.30

70.0%

-8.4%

70.0%

-8.4%

You can edit this narrative until Jul 14 9:19 PM. Then, changes will post as Updates.

Author's Valuation

NOK 75.11

12.2% overvalued

AnalystHighTarget Fair Value

Narrative

Updates0

AnalystHighTarget Fair Value

NOK 75.11

12.2% overvalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

12.96%

Food revenue growth rate

0.49%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

6.16%

Calculation

US$48.67m

Earnings '28

15.47x

PE Ratio '28

US$752.81m

Market Cap '28

US$752.81m

Market Cap '28

85.25m

No. shares '28

US$8.83

Share Price '28

US$8.83 Share Price '28

Discounted to 2025 @ 6.16% p.a.

US$7.38

Fair Value '25

US$7.38 Fair Value '25

Converted to NOK @ 10.2374 USD/NOK Exchange Rate

NOK 75.55

Fair Value '25